Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer

Name: Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
License: Public Domain

City of Hope Medical Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced clear cell renal cell carcinoma, advanced sarcomatoid renal cell carcinoma, metastatic clear cell renal cell carcinoma, metastatic sarcomatoid renal cell carcinoma, stage iii renal cell cancer ajcc v8, stage iv renal cell cancer ajcc v8

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 349958
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.